Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||1.17%||53.48||0.0%||$625.89m|
|VRX||Valeant Pharmaceuticals International, Inc.||0.00%||28.21||14.1%||$165.99m|
|PRGO||Perrigo Co. Plc||0.68%||43.03||6.9%||$139.81m|
|HZNP||Horizon Therapeutics Plc||0.00%||109.76||5.5%||$105.41m|
|JAZZ||Jazz Pharmaceuticals Plc||0.00%||129.10||2.1%||$95.77m|
|INDP||Indaptus Therapeutics, Inc.||0.85%||8.34||0.0%||$93.78m|
|BHC||Bausch Health Cos., Inc.||0.00%||28.21||0.0%||$57.35m|
|AXSM||Axsome Therapeutics, Inc.||2.34%||31.94||1.8%||$55.32m|
|UTHR||United Therapeutics Corp.||0.00%||198.83||14.0%||$49.03m|
|ENDP||Endo International Plc||-0.36%||2.75||8.5%||$48.70m|
|SAGE||SAGE Therapeutics, Inc.||0.00%||45.23||7.6%||$21.01m|
|IRWD||Ironwood Pharmaceuticals, Inc.||0.00%||12.67||9.5%||$20.95m|
Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need, leveraging demonstrated expertise and capabilities in GI diseases. Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller on January 5, 1998 and is headquartered in Boston, MA.